Trident Texofab Ltd - 540726 - Corporate Action-Board recommends Bonus Issue
The Board at its meeting held today has recommended issue of Bonus shares in the proportion of 14 (Fourteen) Equity share of Rs.10/- each for every 10 (Ten) Equity shares of Rs. 10/- each held by the shareholders of the company as on the record date as may be determined by the Board at a later date. Kindly take the above on record. Thank you. Trident Texofab Ltd - 540726 - Board Meeting Intimation for The Audit Committee Meeting And Board Meeting Held On Today Will Continue On Tuesday, June 30, 2020 At 2.00 Pm And 3.30 Pm Respectively
Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2020 ,inter alia, to consider and approve 1. The Audit Committee has not approved the audited financial statement of the Company for the quarter and year ended on March 31, 2020 due to further information required. Therefore the Board of Directors has not considered and approved the audited financial statement of the Company for the quarter and year ended on March 31, 2020. The company now informs that the audit committee meeting and board meeting held on today will continue on Tuesday, June 30, 2020 at 2.00 pm and 3.30 pm respectively to consider the remaining agenda item i.e. audited financial statement of the Company for the quarter and year ended on March 31, 2020. Trident Texofab Ltd - 540726 - Outcome Of The Board Meeting Held On 25.06.2020
Trident Texofab Limited has informed that the board meeting held on today at 1.00 pm and concluded at 3.30 pm has considered and approved following items including- 1. The Audit Committee has not approved the audited financial statement of the Company for the quarter and year ended on March 31, 2020 due to further information required. Therefore the Board of Directors has not considered and approved the audited financial statement of the Company for the quarter and year ended on March 31, 2020. 2. Appointment of Mrs. Vrusti B. Patel as an additional independent director subject to approval of the members. 3.Increase in Authorized Share Capital and Consequent Alteration in the Capital Clause of Memorandum of Association of the Company. 4. Issue of Bonus shares. 5. Migration of the Company from SME segment of BSE Limited to Main Board of BSE Limited. 6. Draft Notice of Postal Ballot. Trident Texofab Ltd - 540726 - Board to consider Bonus Issue
Trident Texofab Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on June 25, 2020, inter alia, including, to consider and approve:-1. The audited Financial Results of the Company for the quarter and year ended on March 31, 2020.2. Appointment of a director.3. Increase in Authorized Share Capital of the Company.4. Issue of Bonus Shares.5. Migration of the Company from SME segment of BSE Limited to Main Board of BSE Limited.Further, Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, read with Code of Conduct framed by the Company and in continuation to our letter dated March 21, 2020 the trading window will remain closed for all designated persons covered under Company's Code of Conduct for Prevention of Insider Trading in Securities from April 01, 2020 to June 29, 2020 (both days inclusive). Trident Texofab Ltd - 540726 - Board Meeting Intimation for Approval Of Audited Financial Results For Quarter And Financial Year Ended March 31, 2020 And Other Matters
Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/06/2020 ,inter alia, to consider and approve including, 1. The audited Financial Results of the Company for the quarter and year ended on March 31, 2020. 2. Appointment of a director. 3. Increase in Authorized Share Capital of the Company. 4. Issue of Bonus Shares. 5. Migration of the Company from SME segment of BSE Limited to Main Board of BSE Limited. 6. Any other business with the permission of the Chair. Trident Texofab Ltd - 540726 - Shareholding for the Period Ended May 30, 2020
Trident Texofab Ltd has submitted to BSE the Shareholding Pattern for the Period Ended May 30, 2020. For more details, kindly Click here Trident Texofab Ltd - 540726 - Outcome Of The Board Meeting Held On 30.05.2020
Please find attached outcome of board meeting of Trident Texofab Limited held on today at 12.00 pm and concluded at 12.55 pm. Trident Texofab Ltd - 540726 - Announcement under Regulation 30 (LODR)-Allotment
The board of director of Trident Texofab Limited has today approved conversion 2,00,000 CCPS into equity shares as per the terms of issue of CCPS and allotted equity shares against it. Post the above conversion, the paid up equity share capital of the company stands increased from Rs. 3,99,58,750/- to Rs. 4,19,58,750/- and CCPS stands reduced from Rs. 20,00,000/- to Rs. 0/-. Please take the same on your record. Thank you. Trident Texofab Ltd - 540726 - Announcement under Regulation 30 (LODR)-Conversion of Securities
Trident Texofab Limited has informed that the board at their meeting held on today at 12.00 pm and concluded at 12.55 pm has considered, approved and taken on record including- Conversion of 2,00,000 CCPS into equity shares as per terms of issue of CCPS. Kindly take the same on record. Thank you. Trident Texofab Ltd - 540726 - Outcome Of The Separate Meeting Of Independent Directors Of The Company
Trident Texofab Limited has submitted outcome of a meeting of Independent Director for the FY 2019-20 held on today at 11.00 am and concluded at 11.35 am. Kindly take on your record. Thank you.